This company has been marked as potentially delisted and may not be actively trading. Bionomics (BNOX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BNOX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Bionomics Ltd – ADR trading halted, news pendingDecember 24, 2024 | markets.businessinsider.comBionomics Limited Receives Court Approval for Re-Domiciliation Scheme to Neuphoria Therapeutics Inc.December 18, 2024 | nasdaq.comBionomics Ltd: Bionomics Announces Supreme Court of New South Wales Approves Bionomics' Re-DomiciliationDecember 18, 2024 | finanznachrichten.deBionomics Announces Supreme Court of New South Wales Approves Bionomics' Re-DomiciliationDecember 16, 2024 | globenewswire.comBionomics Ltd: Results of Scheme MeetingDecember 14, 2024 | finanznachrichten.deResults of Scheme MeetingDecember 12, 2024 | globenewswire.comBionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM EvidenceDecember 9, 2024 | markets.businessinsider.comBionomics to Present at the 2024 American College of Neuropsychopharmacology Annual MeetingDecember 3, 2024 | globenewswire.comBionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United StatesDecember 2, 2024 | globenewswire.comBionomics files $100M mixed securities shelfNovember 19, 2024 | markets.businessinsider.comBionomics Provides an Update on Re-domiciliation via Scheme of ArrangementNovember 8, 2024 | globenewswire.comBionomics receives A$1M milestone payment from Carina Biotech for BNC101November 5, 2024 | markets.businessinsider.comBionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology ProgramNovember 4, 2024 | globenewswire.comWhy Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketOctober 25, 2024 | msn.comBionomics to Present at the ThinkEquity ConferenceOctober 23, 2024 | globenewswire.comBionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLCOctober 14, 2024 | globenewswire.comBionomics CEO believes company has ‘significant, unrealized value’October 8, 2024 | finance.yahoo.comBionomics Limited announces intention to re-domicile to the United StatesOctober 1, 2024 | globenewswire.comBionomics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comBionomics (NASDAQ:BNOX) Stock Quotes, Forecast and News SummaryAugust 24, 2024 | benzinga.comBionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress DisorderJuly 31, 2024 | globenewswire.comBionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024July 29, 2024 | globenewswire.comBionomics Ltd: Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety DisorderJuly 19, 2024 | finanznachrichten.deBuy Rating Affirmed on Bionomics as BNC210 Enters Critical Phase 3 Trial for Social Anxiety DisorderJuly 19, 2024 | markets.businessinsider.comBionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety DisorderJuly 18, 2024 | globenewswire.comBionomics Limited Announces Private Placement of up to $70.0 MillionMay 31, 2024 | globenewswire.comBionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual MeetingMay 20, 2024 | globenewswire.comBionomics Limited (BNOX) Stock Historical Prices & Data - Yahoo FinanceApril 17, 2024 | finance.yahoo.comBuy Rating Affirmed for Bionomics’ BNC210 Following Promising PTSD Study ResultsMarch 27, 2024 | markets.businessinsider.comBionomics Reveals Detailed Data From PTSD Trial, Stock SoarsMarch 21, 2024 | msn.comBionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress DisorderMarch 21, 2024 | globenewswire.comBionomics First Half 2024 Earnings: AU$1.62 loss per share (vs AU$2.16 loss in 1H 2023)March 20, 2024 | finance.yahoo.comBionomics to Present at the 2024 BIO CEO & Investor ConferenceFebruary 22, 2024 | globenewswire.comBionomics Stock (NASDAQ:BNOX), Short Interest ReportFebruary 22, 2024 | benzinga.comBionomics Ltd: Bionomics Provides a Review of 2023 and of 2024 PlansJanuary 22, 2024 | finanznachrichten.deBionomics Provides a Review of 2023 and of 2024 PlansJanuary 22, 2024 | finance.yahoo.comBionomics Ltd ADR BNOXDecember 7, 2023 | morningstar.comMBionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual MeetingDecember 6, 2023 | finance.yahoo.comBionomics Limited (BNOX)December 4, 2023 | ca.finance.yahoo.comBionomics Meets The FDA: Lead Drug Candidate For Social Anxiety Heads To Phase 3October 18, 2023 | benzinga.comPromising Progress of BNC210 Bolsters Buy Rating on Bionomics Amidst Rising Interest in SAD TreatmentsOctober 3, 2023 | markets.businessinsider.comBionomics Full Year 2023 Earnings: AU$3.60 loss per share (vs AU$0.016 loss in FY 2022)September 30, 2023 | finance.yahoo.comBionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244%September 29, 2023 | finance.yahoo.comBionomics’ stock rallies 300% after company reports positive results in trial of PTSD treatmentSeptember 29, 2023 | msn.comBionomics' Victory - Analysts Note Optimism Around Promising Prospects for PTSD TreatmentSeptember 28, 2023 | markets.businessinsider.comBionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)September 28, 2023 | finance.yahoo.comWhy Is Stress Disorder Focused Bionomics Stock Trading Higher Today?September 28, 2023 | msn.comWhy Is Bionomics (BNOX) Stock Up 347% Today?September 28, 2023 | investorplace.comBionomics Limited American Depository Shares (BNOX)September 4, 2023 | nasdaq.comBionomics Ltd: Quarterly Activities and Cashflow ReportJuly 31, 2023 | finanznachrichten.de Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNOX Media Mentions By Week BNOX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNOX News Sentiment▼0.000.77▲Average Medical News Sentiment BNOX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNOX Articles This Week▼01▲BNOX Articles Average Week Get the Latest News and Ratings for BNOX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bionomics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LEXX News Today CMMB News Today LPCN News Today MTEX News Today NAII News Today IBIO News Today BFRG News Today ABP News Today NRSN News Today CLRB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNOX) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
